Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mannkind Corp (NASDAQ:MNKD)

1.48
Delayed Data
As of 4:00pm ET
 +0.03 / +2.07%
Today’s Change
0.64
Today|||52-Week Range
7.32
+2.07%
Year-to-Date

Today’s Trading

Previous close1.45
Today’s open1.43
Day’s range1.38 - 1.50
Volume2,240,683
Average volume (3 months)6,840,419
Market cap$621.8M
Dividend yield--
Data as of 4:00pm ET, 05/03/2016

Growth & Valuation

Earnings growth (last year)-78.43%
Earnings growth (this year)+77.75%
Earnings growth (next 5 years)+26.80%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
DVAXDynavax Technologies...-0.14-0.86%
EGRXEagle Pharmaceutical...+1.30+3.28%
KERXKeryx Biopharmaceuti...-0.32-5.37%
EPZMEpizyme Inc-0.80-7.45%
Data as of 4:00pm ET, 05/03/2016

Financials

Next reporting dateMay 9, 2016
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$0.00
Annual profit (last year)-$368.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
CEO, CFO, Director, VP &
Head-Investor Relations
Matthew J. Pfeffer
Chief Medical Officer
Raymond W. Urbanski
Corporate headquarters
Valencia, California

Forecasts

Partner Offers

Search for Jobs